Skip to content

Clinical trials

Completed Phase 2 Hepatitis C trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Status: Completed Clear all

215 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20025
20032
20046
200511
20068
200710
200810
200922
201025
201118
201211
201321
201417
201513
201610
20177
20184
20194
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences44
Merck Sharp & Dohme LLC17
Bristol-Myers Squibb14
AbbVie (prior sponsor, Abbott)11
National Institute of Allergy and Infectious Diseases (NIAID)11
AbbVie8
ANRS, Emerging Infectious Diseases7
Vertex Pharmaceuticals Incorporated6
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Debiopharm International SA4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C215
Hepatitis C, Chronic58
Hepatitis16
HIV Infections14
Fibrosis12
Liver Diseases11
Liver Cirrhosis7
Bronchiolitis Obliterans Syndrome4
Carcinoma, Hepatocellular4
Infections4

Trials

Showing 1 to 25 of 215. Each trial links to its page on Pharma Observatory.

115 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.